On this episode of Investor Connect, we welcome Dr. Guy Cooper, MD, an orthopedic surgeon by training, who discusses his company’s breakthrough treatment for bladder cancer, the world’s most expensive cancer. Dr. Cooper explains that his company, Combat Medical, is seeking $2.3 million to close a $5 million investment round to further their innovative approach that utilizes heated chemotherapy. This method enhances the drug’s effect, improves penetration into cancer cells, and significantly reduces recurrence and progression rates.

Combat Medical has already conducted over 100,000 procedures outside the US, generating $4.3 million in revenue last year and holding patents that cover their products globally. Dr. Cooper articulates the company’s successful trials and their aggressive expansion plans that project a substantial market growth by 2032. He outlines the potential for significant exit opportunities through acquisition by major medical device companies or IPOs on the Nasdaq.

 

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let’s go startup something today.
________________________________________________________________________

Thank you for joining your host Hall T. Martin with the Startup Funding Espresso — your daily shot of startup funding and investing.
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org
Check out our other podcasts here: https://investorconnect.org/
For Investors check out: https://tencapital.group/investor-landing/
For Startups check out: https://tencapital.group/company-landing/
For eGuides check out: https://tencapital.group/education/
For upcoming Events, check out https://tencapital.group/events/
For Feedback please contact info@tencapital.group
Please follow, share, and leave a review.
Music courtesy of Bensound.

Copyright (c) 2025, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.